Exhibit
4.1


 


DESCRIPTION
OF THE REGISTRANT’S SECURITIES


REGISTERED
PURSUANT TO SECTION 12 OF THE


SECURITIES
EXCHANGE ACT OF 1934


 


﻿OptimizeRx
Corporation has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended:
our common stock, par value $.001 per share (the “common stock”). References herein
to “we,” “us” and “our company” refer to OptimizeRx Corporation  and
not to any of our subsidiaries.


﻿


DESCRIPTION
OF COMMON STOCK


﻿


The following description of the common stock of OptimizeRx
Corporation  is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference
to our articles of incorporation and bylaws, each of which is incorporated by reference
as an exhibit to the Annual Report on Form 10-K of which this Exhibit is a part. We encourage
you to read our articles of incorporation, bylaws and the applicable provisions of the Nevada
Revised Statutes (“NRS”) for additional information.


 


Description of Common Stock


 


Authorized Capitalization


 


Our articles of incorporation
provide for authorized capital stock of 166,666,667 shares of common stock, par value $0.001 per share, and 10,000,000 shares of undesignated
preferred stock, par value $0.001 per share. The rights, preferences and privileges of the holders of common stock are subject to, and
may be adversely affected by, the rights of the holders of shares of any then outstanding preferred stock. As of the date hereof, no shares
of preferred stock are outstanding. Our board of directors, subject to the provisions of our articles of incorporation and limitations
imposed by law, has the authority to designate, from time to time and without stockholder approval, preferred stock in one or more series,
and to prescribe with respect to each such series the voting powers, if any, designations, preferences, and relative, participating, optional,
or other special rights, and the qualifications, limitations, or restrictions relating to such series.


 


Dividend Rights


 


Subject to preferences
that may apply to shares of preferred stock outstanding at the time, the holders of our common stock are entitled to receive dividends
out of assets legally available at the times and in the amounts as our board may from time to time determine.


 


Voting Rights


 


Each holder of record
of our common stock is entitled to one vote for each share of our common stock held on all matters submitted to a vote of the stockholders.
If a quorum is present, unless our articles of incorporation, our bylaws, the rules or regulations of any stock exchange applicable to
us, or applicable law provide for a different proportion, action by the stockholders entitled to vote on a matter, other than the election
of directors, is approved by and is the act of the stockholders if the number of votes cast in favor of the action exceeds the number
of votes cast in opposition to the action. If a quorum is present, unless otherwise provided by our articles of incorporation or bylaws,
directors shall be elected by a plurality of the votes cast.


 


No Preemptive or Other Rights


 


Holders of our common
stock are not entitled to preemptive, subscription, cumulative voting or conversion rights and there are no redemption or sinking fund
provisions applicable to our common stock.


 






     


     


    

 


Right to Receive Liquidation
Distributions


 


In the event of our liquidation,
dissolution or winding up, holders of our common stock will be entitled to share ratably in all assets remaining after payments to creditors
and after satisfaction of the liquidation preference, if any, of the holders of any preferred stock that may at the time be outstanding.


 


Certain Anti-Takeover Effects
of our Articles of Incorporation and Bylaws and Nevada Law


 


Certain provisions of
our articles of incorporation and bylaws, and certain provisions of the NRS may have an effect of delaying, deferring or preventing a
change in control of the Company.


 


Undesignated Preferred
Stock. Our board of directors is authorized to approve the issuance of preferred stock without stockholder approval and to determine
the number of shares, the designations and the relative preferences, rights, restrictions and qualifications of any series of preferred
stock. As a result, our board of directors could, without stockholder approval, authorize the issuance of preferred stock with voting,
dividend, redemption, liquidation, sinking fund, conversion and other rights that could proportionately reduce, minimize or otherwise
adversely affect the voting power and other rights of holders of the Company’s capital stock or that could have the effect of delaying,
deferring or preventing a change in control.


 


No Stockholder Action
by Written Consent. Our bylaws prohibit stockholders from acting by written consent. Accordingly, stockholder action must take
place at an annual or a special meeting of the Company’s stockholders.


  


Board Vacancies. 
Subject to any rights of the holders of preferred stock, if any, vacancies on our board of directors, howsoever resulting, may be filled
only by a majority of the remaining directors, even if less than a quorum, or by a sole remaining director. Any director elected to fill
a vacancy shall hold office for a term expiring at the next annual meeting of stockholders and until such director’s successor is
duly elected and qualified.


 


Removal of Directors. Our
bylaws provide that, subject to any rights of the holders of preferred stock, if any, and except as otherwise provided in the NRS, any
director, or the entire Board, may be removed from office by the affirmative vote of the holders of not less than two-thirds of the voting
power of the issued and outstanding stock entitled to vote at an annual or special meeting of the stockholders duly noticed and called
in accordance with our bylaws. NRS 78.335 generally requires the vote of stockholders representing not less than two-thirds of the voting
power of the issued and outstanding stock entitled to vote in order to remove an incumbent director.


 


 Advance Notice
Requirements.  Stockholders wishing to nominate persons for election to our board of directors at an annual meeting or to
propose any business to be considered by our stockholders at an annual or special meeting must comply with certain advance notice and
other requirements set forth in our bylaws. Likewise, if our board of directors has determined that directors shall be elected at a special
meeting of stockholders, stockholders wishing to nominate persons for election to our board of directors at such special meeting must
comply with certain advance notice and other requirements set forth in our bylaws.


 


Nevada Anti-Takeover
Statutes. Nevada’s “acquisition of controlling interest” statutes (NRS 78.378 through 78.3793, inclusive) contain
provisions governing the acquisition of a controlling interest in certain Nevada corporations. These “control share” laws
provide generally that any person that acquires a “controlling interest” in certain Nevada corporations may be denied voting
rights, unless a majority of the disinterested stockholders of the corporation elects to restore such voting rights. These laws would
apply to us as of a particular date if we were to have 200 or more stockholders of record (at least 100 of whom have addresses in Nevada
appearing on our stock ledger at all times during the 90 days immediately preceding that date) and do business in the State of Nevada
directly or through an affiliated corporation, unless our articles of incorporation or bylaws in effect on the tenth day after the acquisition
of a controlling interest provide otherwise. These laws provide that a person acquires a “controlling interest” whenever a
person acquires shares of a subject corporation that, but for the application of these provisions of the NRS, would enable that person
to exercise (1) one-fifth or more, but less than one-third, (2) one-third or more, but less than a majority or (3) a majority or more,
of all of the voting power of the corporation in the election of directors. Once an acquirer crosses one of these thresholds, shares which
it acquired in the transaction taking it over the threshold and within the 90 days immediately preceding the date when the acquiring person
acquired or offered to acquire a controlling interest become “control shares” to which the voting restrictions described above
apply. 


 






    2


     


    

 


Nevada’s “combinations
with interested stockholders” statutes (NRS 78.411 through 78.444, inclusive) provide that specified types of business “combinations”
between certain Nevada corporations and any person deemed to be an “interested stockholder” of the corporation are prohibited
for two years after such person first becomes an “interested stockholder” unless the corporation’s board of directors
approves the combination (or the transaction by which such person becomes an “interested stockholder”) in advance, or unless
the combination is approved by the board of directors and at least sixty percent of the corporation’s voting power not beneficially
owned by the interested stockholder, its affiliates and associates. Furthermore, in the absence of prior approval certain restrictions
may apply even after such two-year period. For purposes of these statutes, an “interested stockholder” is any person who is
(1) the beneficial owner, directly or indirectly, of 10% or more of the voting power of the outstanding voting shares of the corporation,
or (2) an affiliate or associate of the corporation and at any time within the two previous years was the beneficial owner, directly or
indirectly, of 10% or more of the voting power of the then-outstanding shares of the corporation. The definition of the term “combination”
is sufficiently broad to cover most significant transactions between a corporation and an “interested stockholder.” These
laws generally apply to Nevada corporations with 200 or more stockholders of record.


 


In addition, NRS 78.139
also provides that directors may resist a change or potential change in control of the corporation if the board of directors determines
that the change or potential change is opposed to or not in the best interest of the corporation upon consideration of any relevant facts,
circumstances, contingencies or constituencies pursuant to NRS 78.138(4).


 


 


3